Early and late chaperone intervention therapy boosts XBP1s and ADAM10, restores proteostasis, and rescues learning in Alzheimer's Disease mice
Hafycz, J. M.; Strus, E.; Naidoo, N.
Show abstract
Alzheimers disease (AD) is a debilitating neurodegenerative disorder that is pervasive among the aging population. Two distinct phenotypes of AD are deficits in cognition and proteostasis, including chronic activation of the unfolded protein response (UPR) and aberrant A{beta} production. It is unknown if restoring proteostasis by reducing chronic and aberrant UPR activation in AD can improve pathology and cognition. Here, we present data using an APP knock-in mouse model of AD and several protein chaperone supplementation paradigms, including a late-stage intervention. We show that supplementing protein chaperones systemically and locally in the hippocampus reduces PERK signaling and increases XBP1s, which is associated with increased ADAM10 and decreased A{beta}42. Importantly, chaperone treatment improves cognition which is correlated with increased CREB phosphorylation and BDNF. Together, this data suggests that chaperone treatment restores proteostasis in a mouse model of AD and that this restoration is associated with improved cognition and reduced pathology. One-sentence summaryChaperone therapy in a mouse model of Alzheimers disease improves cognition by reducing chronic UPR activity
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Amelioration of symptomatic Alzheimer's Disease after selective impairment of p75NTR function in adult forebrainexcitatory neurons 97%
- Increased neuronal expression of the early endosomal adaptor APPL1 replicates Alzheimer's Disease-related endosomal and synaptic dysfunction with cholinergic neurodegeneration 95%
- Heightened β-adrenergic receptor function in the TgF344-AD rat model drives synaptic potentiation and supports learning and memory 95%
Similar papers in this journal
- CCR5 deficiency normalizes TIMP levels, working memory, and gamma oscillation power in APOE4 targeted replacement mice 96%
- Loss of excitatory inputs and decreased tonic and evoked activity of locus coeruleus neurons in aged P301S mice 94%
- Ethanol exposure alters Alzheimer's-related pathology, behavior, and metabolism in APP/PS1 mice 94%
Similar papers in this journal
- Aβ/APP-induced hyperexcitability and dysregulation of homeostatic synaptic plasticity in models of Alzheimer's disease 95%
- Dysregulated calcium signaling in the aged macaque entorhinal cortex associated with tau hyperphosphorylation. 95%
- Dual-specificity protein phosphatase 6 (DUSP6) overexpression reduces amyloid load and improves memory deficits in male 5xFAD mice 94%
Similar papers in this journal
- Modeling human age-associated increase in Gadd45γ expression leads to spatial recognition memory impairments in young adult mice 95%
- Reduced firing rates of pyramidal cells in frontal cortex of APP/PS1 can be restored by acute treatment with levetiracetam 94%
- Age-dependent dysregulation of locus coeruleus firing in a transgenic rat model of Alzheimers disease 93%
Similar papers in this journal
- Choline supplementation in early life improves and low levels of choline can impair outcomes in a mouse model of Alzheimer's disease. 95%
- Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer's disease, restores synapse integrity and memory in a disease mouse model 95%
- APP β-CTF triggers cell-autonomous synaptic toxicity independent of Aβ 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.